Skip NavigationSkip to Content

Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment

  1. Author:
    Wang, Wei
    Uberoi, Aayushi [ORCID]
    Spurgeon, Megan [ORCID]
    Gronski, Ellery
    Majerciak,Vladimir
    Lobanov, Alexei
    Hayes, Mitchell [ORCID]
    Loke, Amanda [ORCID]
    Zheng, Zhi-Ming [ORCID]
    Lambert, Paul F [ORCID]
  2. Author Address

    McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI, United States of America., Department of Dermatology, University of Pennsylvania, Philadelphia, PA, United States of America., Tumor Virus RNA Biology Section, National Cancer Institute, Frederick, MD, United States of America., CCR Collaborative Bioinformatics Resource (CCBR), National Cancer Institute, Bethesda, MD, United States of America.,
    1. Year: 2020
    2. Date: Jan
    3. Epub Date: 2020 01 22
  1. Journal: PLoS pathogens
    1. 16
    2. 1
    3. Pages: e1008206
  2. Type of Article: Article
  3. Article Number: e1008206
  4. ISSN: 1553-7366
  1. Abstract:

    High-risk human papillomaviruses (HPVs) cause 5% of human cancers. Despite the availability of HPV vaccines, there remains a strong urgency to find ways to treat persistent HPV infections, as current HPV vaccines are not therapeutic for individuals already infected. We used a mouse papillomavirus infection model to characterize virus-host interactions. We found that mouse papillomavirus (MmuPV1) suppresses host immune responses via overexpression of stress keratins. In mice deficient for stress keratin K17 (K17KO), we observed rapid regression of papillomas dependent on T cells. Cellular genes involved in immune response were differentially expressed in the papillomas arising on the K17KO mice correlating with increased numbers of infiltrating CD8+ T cells and upregulation of IFN?-related genes, including CXCL9 and CXCL10, prior to complete regression. Blocking the receptor for CXCL9/CXCL10 prevented early regression. Our data provide a novel mechanism by which papillomavirus-infected cells evade host immunity and defines new therapeutic targets for treating persistent papillomavirus infections.

    See More

External Sources

  1. DOI: 10.1371/journal.ppat.1008206
  2. PMID: 31968015
  3. WOS: 000510746400041
  4. PII : PPATHOGENS-D-19-01657

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel